Avian Influenza Virus Type A H7N7 subtype NP antibody and antigen (recombinant protein)

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-VT-P188-Tg001-Ag01	Recombinant Avian Influenza Virus Type A H7N7 subtype NP protein	3090
GMP-VT-P188-Tg001-Ab01	Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P188-Tg001-Ab02	Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P188-Tg001-Ab03	Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P188-Tg001-Ab04	Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-VT-P188-Tg001-Ag01
Product Name	Recombinant Avian Influenza Virus Type A H7N7 subtype NP protein
Pathogen	Avian Influenza Virus Type A H7N7 subtype
Target/Biomarker	NP
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Avian Influenza Virus Type A H7N7 subtype NP antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Avian Influenza Virus Type A H7N7 subtype level test of animal Avian/Bird/Poultry with Avian Influenza Virus Type A H7N7 subtype infection.
Tag	His
Products description	Recombinant Avian Influenza Virus Type A H7N7 subtype NP protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-VT-P188-Tg001-Ab01, GMP-VT-P188-Tg001-Ab02, GMP-VT-P188-Tg001-Ab03, GMP-VT-P188-Tg001-Ab04
Product Name	Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb)
Pathogen	Avian Influenza Virus Type A H7N7 subtype
Target/Biomarker	NP
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Avian Influenza Virus Type A H7N7 subtype NP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Avian Influenza Virus Type A H7N7 subtype antibodies in Avian Influenza Virus Type A H7N7 subtype level test of animal Avian/Bird/Poultry with Avian Influenza Virus Type A H7N7 subtype infection.
Tag	mFc
Products description	Anti-Avian Influenza Virus Type A H7N7 subtype NP mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

he spread of highly pathogenic avian influenza (HPAI) viruses of H5 or H7 subtypes and low pathogenic avian influenza (LPAI) viruses of H5, H7 or H9 subtypes amongst birds and sporadic infection in humans continues to pose a threat to public health. In 2003, 89 people were confirmed as being infected with HPAI H7N7 in the Netherlands with evidence of limited person to person transmission, which was associated with an outbreak of HPAI H7N7 in chickens in over 200 farms [4], [5]. In 2007, four cases infected with LPAI H7N2 were identified after an outbreak of LPAI H7N2 in chickens on a small farm in north Wales in the United Kingdom [6].

About GDU